Sorry, this section is only available in Japanese.
著者 (40件)：
資料名：
巻： 13 ページ： 854630 発行年： 2022年
JST資料番号： U7080A ISSN： 1664-302X 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： スイス (CHE) 言語： 英語 (EN)
前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202267203051435
整理番号：22A1316178
交差反応物質197Aドメインと融合した細菌発現SARS-CoV-2受容体結合ドメインはマウスにおける高レベルの中和抗体を誘導する【JST・京大機械翻訳】
A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
Liu Liqin
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Liu Liqin
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Chen Tingting
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Chen Tingting
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zhou Lizhi
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zhou Lizhi
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Sun Jie
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Sun Jie
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Li Yuqian
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Li Yuqian
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Nie Meifeng
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Nie Meifeng
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Xiong Hualong
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Xiong Hualong
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zhu Yuhe
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zhu Yuhe
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Xue Wenhui
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Xue Wenhui
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Wu Yangtao
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Wu Yangtao
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Li Tingting
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Li Tingting
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zhang Tianying
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zhang Tianying
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Kong Zhibo
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Kong Zhibo
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Yu Hai
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Yu Hai
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zhang Jun
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zhang Jun
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Gu Ying
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Gu Ying
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zheng Qingbing
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zheng Qingbing
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Zhao Qinjian
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Zhao Qinjian
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Xia Ningshao
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Xia Ningshao
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
,
Li Shaowei
(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China)
,
Li Shaowei
(National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China)
資料名：
Frontiers in Microbiology (Web)
(Frontiers in Microbiology (Web))
巻： 13 ページ： 854630 発行年： 2022年
JST資料番号： U7080A ISSN： 1664-302X 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： スイス (CHE) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。